Label: ABRILADA- adalimumab-afzb injection, solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated November 9, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • PRINCIPAL DISPLAY PANEL

    127-102-303 0.4mLCarton127-102-303 0.4mLCarton127-102-303 0.4mLCase.jpg127-102-303 0.4mLCase.jpg

  • INGREDIENTS AND APPEARANCE
    ABRILADA 
    adalimumab-afzb injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61434-053
    Route of AdministrationSUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ADALIMUMAB-AFZB (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-AFZB20 mg  in 0.4 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61434-053-0040 in 1 CASE01/14/2021
    12 in 1 CARTON
    10.4 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    export only01/14/2021
    Labeler - Catalent Indiana, LLC (172209277)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!